Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Jan;78(1):611-5.
doi: 10.1073/pnas.78.1.611.

Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma

Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma

W Stoffel et al. Proc Natl Acad Sci U S A. 1981 Jan.

Abstract

Studies were undertaken to determine the applicability and effectiveness of immunoadsorption chromatography on anti-low density lipoprotein (LDL) columns as a plasma-cholesterol-lowering procedure. Mass production and isolation of monospecific antibodies against swine LDL (rho = 1.006-1.063 g/ml) was carried out by immunization of sheep with swine LDL and selective antibody adsorption from their antisera by chromatography on LDL-Sepharose. The isolated LDL antibodies were then covalently linked to Sepharose CL-4B. Pig plasma LDL was effectively removed in vitro by the anti-LDL-Sepharose beads. In vivo studies were performed in pigs with (i) a plasma-separator membrane permeable to solutes below Mr 2,000,000 or (ii) a blood centrifuge interposed into an arteriovenous shunt to separate the corpuscular elements of blood from the plasma. In either case, the plasma was passed through the anti-LDL-Sepharose column and recirculated into the venous part of the shunt. Plasma cholesterol levels were reduced 70-80% by this procedure and rebounded 3-4 days after the extracorporeal immunoadsorption procedure. This continuous plasma separation-immunoadsorption procedure may have broad applicability for the elimination of any plasma component with antigenic properties.

PubMed Disclaimer

References

    1. Immunochemistry. 1965 Sep;2(3):235-54 - PubMed
    1. J Clin Invest. 1955 Sep;34(9):1345-53 - PubMed
    1. Biochem J. 1971 Oct;124(4):677-83 - PubMed
    1. J Clin Invest. 1972 Jun;51(6):1528-36 - PubMed
    1. Res Exp Med (Berl). 1972;157(4):300-16 - PubMed

Publication types

MeSH terms

LinkOut - more resources